Inhibition by Local Bupivacaine-Releasing Microspheres of Acute Postoperative Pain from Hairy Skin Incision
Authors:
- Jeffrey Chi-Fei WangJWJeffrey Chi-Fei Wang
- Phillip D. BlaskovichPBPhillip D. Blaskovich
- Lan N. PhamLPLan N. Pham
- Daniel S. CostaDCDaniel S. Costa
- Gary A. NicholsGNGary A. Nichols
- William P. HildebrandWHWilliam P. Hildebrand
- Nelson L. ScarboroughNSNelson L. Scarborough
- Clifford J. HermanCHClifford J. Herman
- Gary R. StrichartzGSGary R. Strichartz
- 1 September 2013
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 117 (3) , 717-730
Abstract
Ted here. METHODS: We subcutaneously injected a new formulation of poly-lactic-co-glycolic acid polymer microspheres, which provides steady drug release for 96+ hours into rats at the dorsal region 2 hours before surgery. A single 1.2-cm-long skin incision was followed by blunt dissection of skin away from the underlying fascia, and closed by 2 sutures, followed by 14 days of testing. Microspheres containing 5, 10, 20, and 40 mg bupivacaine were injected locally 2 hours before surgery; bupivacaine-free microspheres were the vehicle control, and bupivacaine HCl solution (0.5%), the positive control. Mechanical sensitivity was determined by the frequency of local muscle contractions to repeated pokes with nylon monofilaments (von Frey hairs) exerting 4 and 15 g forces, testing, respectively, allodynia and hyperalgesia, and by pinprick. RESULTS: Injection of bupivacaine microspheres (40 mg drug) into intact skin reduced responses to 15 g von Frey hairs for 6 hours and to pinprick for 36 hours. Respective reductions from bupivacaine HCl lasted for 3 and 2 hours. Skin incision and dissection alone caused mechanical allodynia and hyperalgesia for 14 days. Microspheres containing 20 or 40 mg bupivacaine suppressed postoperative hypersensitivity for up to 3 days, reduced integrated allodynia (area under curve of response versus time) over postoperative days 1 to 5 by 51% ± 20% (mean ± SE) and 78% ± 12%, and reduced integrated hyperalgesia by 55% ± 13% and 64% ± 11%, for the respective doses. Five and ten milligrams bupivacaine in microspheres and the 0.5% bupivacaine solution were ineffective in reducing postoperative hypersensitivity, as were 40 mg bupivacaine microspheres injected contralateral to the incision. CONCLUSIONS: Significant suppression of postoperative pain by the slow-release bupivacaine preparation outlasts its anesthetic action on intact skin. These findings demonstrate preventive analgesia and indicate the importance of acute processes in the development of chronic postoperative pain....Keywords
This publication has 56 references indexed in Scilit:
- Prolonged Nerve Block by Microencapsulated Bupivacaine Prevents Acute Postoperative Pain in RatsRegional Anesthesia & Pain Medicine, 2012
- Higuchi equation: Derivation, applications, use and misuseInternational Journal of Pharmaceutics, 2011
- Effect of local and intravenous lidocaine on ongoing activity in injured afferent nerve fibersPain, 2011
- Prolonged Suppression of Postincisional Pain by a Slow-release Formulation of LidocaineAnesthesiology, 2011
- Contribution of the Chemokine (C-C Motif) Ligand 2 (CCL2) to Mechanical Hypersensitivity after Surgical Incision in RatsAnesthesiology, 2010
- Guarding Pain and Spontaneous Activity of Nociceptors after Skin versus Skin Plus Deep Tissue IncisionAnesthesiology, 2010
- Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgeryBritish Journal of Surgery, 2008
- C-fiber spontaneous discharge evoked by chronic inflammation is suppressed by a long-term infusion of lidocaine yielding nanogram per milliliter plasma levelsPain, 2008
- Reduction of Postincisional Allodynia by Subcutaneous BupivacaineAnesthesiology, 2005
- Characterization of a rat model of incisional painPain, 1996